NEW YORK (
) hit a new 52-week high Wednesday as it traded at $78.13 compared with its previous 52-Week high of $77.96. Perrigo is changing hands at $78.13 with 16,650 shares traded as of 9:31 a.m. ET. Average volume has been 818,600 shares over the past 30 days.
Perrigo has a market cap of $7 billion and is part of the
industry. Shares are up 21.6% year to date as of the close of trading on Tuesday.
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, infant formulas, active pharmaceutical ingredients (API), and pharmaceutical and medical diagnostic products worldwide. The company has a P/E ratio of 25.9, equal to the average drugs industry P/E ratio and above the S&P 500 P/E ratio of 16.1.
- Practice your PRGO trading strategies and win cash in our stock game.
TheStreet Ratings rates Perrigo as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full
52-week high stocks
or get investment ideas from our